Xcout IntelSign inSubscribe

Novus Therapeutics, Inc.

BiotechnologyUnited States

Novus Therapeutics, Inc. is a clinical-stage public biotechnology company headquartered in Irvine, California, focused on the acquisition and development of pharmaceutical and therapeutic products.

Subscribe to see Novus Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Novus Therapeutics, Inc. at a glance

Novus Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $109.9M across the 3 funding rounds on record. Its most recent funding round raised $108.1M in September 2020. Xcout tracks 12 named people at Novus Therapeutics, Inc., including David-Alexandre C. Gros (Chief Executive Officer).

Industry
Biotechnology
Headquarters
United States
Raised, rounds on record
$109.9M

Novus Therapeutics, Inc. leadership

  • David-Alexandre C. GrosChief Executive Officer
  • Paul Little, PhDChief Financial Officer
  • David HovlandChief Regulatory Officer
  • Bryan SmithGeneral Counsel
  • Steven PerrinPresident and Chief Scientific Officer
  • Carlos CandidoVice President, Cell Therapy Operations

6 more named people on record for Novus Therapeutics, Inc., with roles, board committees and tenure — see the full roster →

Novus Therapeutics, Inc. funding rounds

At least $109.9M raised across the 3 rounds on record. Every round on record:

DateRoundAmountInvestors
SEC Form D filing$108.1M—
SEC Form D filing$862,278—
SEC Form D filing$862,278—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Novus Therapeutics, Inc. competitors

A few of Novus Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →

Get Novus Therapeutics, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Novus Therapeutics, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Novus Therapeutics, Inc. in Xcout Intel

  • 12 named people with titles, LinkedIn and board committees
  • 3 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →